Time toxicity and shared decision-making in cerebral palsy.
David B Frumberg1, Paige T Church2, Nathan Rosenberg3
1Yale School of Medicine, Department of Orthopaedics & Rehabilitation, New Haven, CT, USA.
Developmental Medicine and Child Neurology
|December 12, 2025
Summary
Time toxicity, or time-related burdens, is often overlooked in shared medical decisions for individuals with disabilities. This study proposes incorporating time toxicity into healthcare outcome measures for better patient-centered care.
Area of Science:
- Healthcare research
- Disability studies
- Patient-centered outcomes
Background:
- Shared decision-making between clinicians and families is common in healthcare.
- Time-related burdens, or "time toxicity," are increasingly recognized in oncology but often ignored in other fields, like cerebral palsy research.
- The impact of unaddressed time-related burdens on individuals with disabilities is largely unknown.
Purpose of the Study:
- To introduce and advocate for the inclusion of "time toxicity" as a critical outcome measure in healthcare for people with disabilities.
- To build upon existing research in oncology to adapt the concept of time toxicity for a broader patient population.
- To highlight the potential profound effects of time-related burdens that are currently unaccounted for in disability research.
Main Methods:
- This study is conceptual, building upon existing literature from oncology.
- It proposes applying the "time toxicity" framework to individuals with disabilities who frequently interact with the healthcare system.
- Qualitative or quantitative research methods would be needed to formally assess time toxicity in this population.
Main Results:
- Currently, time-related burdens are not systematically measured as an outcome in disability healthcare, particularly for conditions like cerebral palsy.
- The lack of measurement suggests a potential gap in understanding the full impact of healthcare interventions on patients' lives.
- The concept of "time toxicity" offers a novel lens to evaluate patient experience and burden.
Conclusions:
- Time toxicity is a significant, yet understudied, factor in the healthcare experiences of people with disabilities.
- Integrating time toxicity into outcome measures can lead to more comprehensive and patient-centered care plans.
- Further research is needed to quantify and address time-related burdens in disability healthcare.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Metabolism
174
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
174
Factors Affecting Drug Response: Overview
2.8K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.8K
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
602
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
602
Pharmacokinetics in Pediatric Patients: Drug Excretion
194
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
194


